The urine microRNA profile may help monitor post-transplant renal graft function

Al-Awwa, 1998, Importance of allograft biopsy in renal transplant recipients: correlation between clinical and histological diagnosis, Am J Kidney Dis, 31, S15, 10.1053/ajkd.1998.v31.pm9631859 John, 2010, Our approach to a renal transplant biopsy, J Clin Pathol, 63, 26, 10.1136/jcp.2009.067983 Kozakowski, 2009, Biopsy diagnostics in renal allograft rejection: from histomorphology to biological function, Transpl Int, 22, 945, 10.1111/j.1432-2277.2009.00885.x Mannon, 2006, Beyond histology: novel tools to diagnose allograft dysfunction, Clin J Am Soc Nephrol, 1, 358, 10.2215/CJN.01681105 Gourishankar, 2010, Pathological and clinical characterization of the ‘troubled transplant’: data from the DeKAF study, Am J Transplant, 10, 324, 10.1111/j.1600-6143.2009.02954.x Rush, 2009, Can protocol biopsy better inform our choices in renal transplantation?, Transplant Proc, 41, S6, 10.1016/j.transproceed.2009.06.092 Lezaic, 2004, Donor kidney glomerular filtration rate and post-transplant graft function, Am J Transplant, 4, 1669, 10.1111/j.1600-6143.2004.00553.x Bargnoux, 2012, Accuracy of GFR predictive equations in renal transplantation: validation of a new turbidimetric cystatin C assay on Architect c8000. Biology of renal function and renal failure working group, Clin Biochem, 45, 151, 10.1016/j.clinbiochem.2011.10.018 Buron, 2011, Estimating glomerular filtration rate in kidney transplant recipients: performance over time of four creatinine-based formulas, Transplantation, 92, 1005, 10.1097/TP.0b013e3182301602 Eriksen, 2012, The role of cystatin C in improving GFR estimation in the general population, Am J Kidney Dis, 59, 32, 10.1053/j.ajkd.2011.09.001 Delanaye, 2012, Estimating glomerular filtration rate in 2012: Which adding value for the CKD-EPI equation?, Nephrol Ther, 8, 199, 10.1016/j.nephro.2012.03.002 Diamantidis, 2012, A varying patient safety profile between Black and nonBlack adults with decreased estimated GFR, Am J Kidney Dis., 60, 47, 10.1053/j.ajkd.2012.01.023 Kwong, 2010, Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations, Am J Kidney Dis, 56, 39, 10.1053/j.ajkd.2010.02.347 Ju, 2012, Genomic biomarkers for chronic kidney disease, Transl Res, 159, 290, 10.1016/j.trsl.2012.01.020 Fassett, 2011, Biomarkers in chronic kidney disease: a review, Kidney Int, 80, 806, 10.1038/ki.2011.198 Perkins, 2011, Advances of genomic science and systems biology in renal transplantation: a review, Semin Immunopathol, 33, 211, 10.1007/s00281-011-0243-2 Patel, 2012, MicroRNAs and fibrosis, Curr Opin Nephrol Hypertens, 21, 410, 10.1097/MNH.0b013e328354e559 Kong, 2012, MicroRNAs in cancer management, Lancet Oncol, 13, e249, 10.1016/S1470-2045(12)70073-6 Beltrami, 2012, Analysis of urinary microRNAs in chronic kidney disease, Biochem Soc Trans, 40, 875, 10.1042/BST20120090 Matheson, 2010, Urinary biomarkers involved in type 2 diabetes: a review, Diabetes Metab Res Rev, 26, 150, 10.1002/dmrr.1068 Caubet, 2010, Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease, Pediatr Nephrol, 25, 27, 10.1007/s00467-009-1251-5 Afaneh, 2010, Urinary cell levels of mRNA for OX40,OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts, Transplantation, 90, 1381, 10.1097/TP.0b013e3181ffbadd Muthukumar, 2005, Messenger RNA for FOXP3 in the urine of renal-allograft recipients, N Engl J Med, 353, 2342, 10.1056/NEJMoa051907 Dadhania, 2010, Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers, Transplantation, 90, 189, 10.1097/TP.0b013e3181e2a932 Mas, 2007, Establishing the molecular pathways involved in chronic allograft nephropathy for testing new noninvasive diagnostic markers, Transplantation, 83, 448, 10.1097/01.tp.0000251373.17997.9a Mas, 2007, Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function, Mol Med, 13, 315, 10.2119/2007-00017.Mas Sui, 2008, Microarray analysis of microRNA expression in acute rejection after renal transplantation, Transpl Immunol, 19, 81, 10.1016/j.trim.2008.01.007 Anglicheau, 2009, MicroRNA expression profiles predictive of human renal allograft status, Proc Natl Acad Sci USA, 106, 5330, 10.1073/pnas.0813121106 Lorenzen, 2011, Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients, Am J Transplant, 11, 2221, 10.1111/j.1600-6143.2011.03679.x Scian, 2011, MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA, Am J Transplant, 11, 2110, 10.1111/j.1600-6143.2011.03666.x Sales, 2010, MAGIA, a web-based tool for miRNA and Genes Integrated Analysis, Am J Transplant, 38, W352 Bisognin, 2012, MAGIA2: from miRNA and genes expression data integrative analysis to microRNA-transcription factor mixed regulatory circuits (2012 update), Nucleic Acids Res, 40, W13, 10.1093/nar/gks460 He, 2012, Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD, J Am Soc Nephrol, 23, 294, 10.1681/ASN.2011050490 Szeto, 2006, mRNA expression of target genes in the urinary sediment as a noninvasive prognostic indicator of CKD, Am J Kidney Dis, 47, 578, 10.1053/j.ajkd.2005.12.027 Wang, 2007, Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy, Nephron Clin Pract, 106, c169, 10.1159/000104428 Scian, 2011, Gene expression changes are associated with loss of kidney graft function and interstitial fibrosis and tubular atrophy: diagnosis versus prediction, Transplantation, 91, 657, 10.1097/TP.0b013e3182094a5a Shannon, 2003, Cytoscape: a software environment for integrated models of biomolecular interaction networks, Genome Res, 13, 2498, 10.1101/gr.1239303 Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group, 2009, KDIGO clinical practice guideline for the care of kidney transplant recipients, Am J Transplant, 9, S1 Solez, 2008, Banff 07 classification of renal allograft pathology: updates and future directions, Am J Transplant, 8, 753, 10.1111/j.1600-6143.2008.02159.x Chandrasekaran, 2012, Role of microRNAs in kidney homeostasis and disease, Kidney Int, 81, 617, 10.1038/ki.2011.448 Bhatt, 2011, MicroRNAs in kidneys: biogenesis, regulation, and pathophysiological roles, Am J Physiol Renal Physiol, 300, F602, 10.1152/ajprenal.00727.2010 Kato, 2012, MicroRNA circuits in transforming growth factor-β actions and diabetic nephropathy, Semin Nephrol, 32, 253, 10.1016/j.semnephrol.2012.04.004 Li, 2010, Review: the role of microRNAs in kidney disease, Nephrology (Carlton), 15, 599, 10.1111/j.1440-1797.2010.01363.x Elias, 2012, Battle of the midgets: innate microRNA networking, RNA Biol, 9, 792, 10.4161/rna.19717 Liston, 2012, MicroRNA-29 in the adaptive immune system: setting the threshold, Cell Mol Life Sci, 69, 3533, 10.1007/s00018-012-1124-0 Hu, 2013, MicroRNA control in the development of systemic autoimmunity, Arthritis Res Ther, 15, 202, 10.1186/ar4131 Merkerova, 2008, Differential expression of microRNAs in hematopoietic cell lineages, Eur J Haematol, 81, 304, 10.1111/j.1600-0609.2008.01111.x Chen, 2004, MicroRNAs modulate hematopoietic lineage differentiation, Science, 303, 83, 10.1126/science.1091903 Huang, 2009, MiR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA, EMBO Rep, 10, 180, 10.1038/embor.2008.224 Medrano, 2012, Two microRNAs, miR-330 and miR-125b-5p, mark the juxtaglomerular cell and balance its smooth muscle phenotype, Am J Physiol Renal Physiol, 302, F29, 10.1152/ajprenal.00460.2011 Tili, 2007, Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock, J Immunol, 179, 5082, 10.4049/jimmunol.179.8.5082 Tsitsiou, 2009, MicroRNAs and the immune response, Curr Opin Pharmacol, 9, 514, 10.1016/j.coph.2009.05.003 Sonkoly, 2008, MicroRNAs: novel regulators in skin inflammation, Clin Exp Dermatol, 33, 312, 10.1111/j.1365-2230.2008.02804.x Malumbres, 2009, Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas, Blood, 113, 3754, 10.1182/blood-2008-10-184077 Chaudhuri, 2011, MicroRNA-125b potentiates macrophage activation, J Immunol, 187, 5062, 10.4049/jimmunol.1102001 Primo, 2012, Regulation of pro-inflammatory cytokines TNFα and IL24 by microRNA-203 in primary keratinocytes, Cytokine, 60, 741, 10.1016/j.cyto.2012.07.031 Maluf, 2008, Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis, Mol Med, 14, 276, 10.2119/2007-00111.Maluf Tang, 2013, MiRNA-200b represses transforming growth factor beta1-induced EMT and fibronectin expression in kidney proximal tubular cells, Am J Physiol Renal Physiol, 304, F1266, 10.1152/ajprenal.00302.2012 Xiong, 2012, The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression, Am J Physiol Renal Physiol, 302, F369, 10.1152/ajprenal.00268.2011 Levey, 1999, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group, Ann Intern Med, 130, 461, 10.7326/0003-4819-130-6-199903160-00002 Noma, 2012, The optimal discovery procedure in multiple significance testing: anempirical Bayes approach, Stat Med, 31, 165, 10.1002/sim.4375 Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J R Stat Soc Ser B, 57, Z289